Close

Glaukos Corporation (GKOS) Says Study Reveals Potential Cost Efficiency of Using Two iStent Trabecular Micro-Bypass Stents

May 22, 2017 4:38 PM EDT Send to a Friend
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login